Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization

American Journal of Clinical Pathology

Volumn 137, Issue 6, 2012, Pages 904-908

  Fritsma, George A ^a,b   Dembitzer, Francine R ^c   Randhawa, Ankush ^d   Marques, Marisa B ^a   Van Cott, Elizabeth M ^e   Adcock Funk, Dorothy ^f   Peerschke, Ellinor I ^c  

^a University of Alabama at Birmingham   (United States)

^b Your Interactive Hemostasis Resource   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Precision BioLogic   (Canada)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f Esoterix Inc   (United States)

Author keywords

Activated partial thromboplastin time; aPTT; Lupus anticoagulant; Reagent; Routine coagulation

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LUPUS ANTICOAGULANT; REAGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; IMMUNOLOGIC FACTOR;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR DEFICIENCY; INTERNET; LABORATORY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; BLOOD; BLOOD CLOTTING TEST; CLASSIFICATION; HUMAN; INFORMATION PROCESSING; METHODOLOGY; PRACTICE GUIDELINE; SENSITIVITY AND SPECIFICITY; STANDARD; TIME;

ANTICOAGULANTS; BLOOD COAGULATION TESTS; DATA COLLECTION; HEPARIN; HUMANS; IMMUNOLOGIC FACTORS; INDICATORS AND REAGENTS; INTERNET; LUPUS COAGULATION INHIBITOR; PARTIAL THROMBOPLASTIN TIME; PRACTICE GUIDELINES AS TOPIC; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84863767302     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP3J1ZKYBFQXJM     Document Type: Article

References (12)

1. Brinkhous KM, Langdell RD, Penick GD, et al. Newer approaches to the study of hemophilia and hemophilioid states. JAMA. 1954;154:481-486.
2. Triplett DA, Smith C. Routine testing in the coagulation laboratory. In: Triplett DA. Laboratory Evaluation of Coagulation. Chicago, IL: ASCP Press; 1983:27-52.
3. van den Besselaar AM, Neuteboom J, Meeuwisse-Braun J, et al. Preparation of lyophilized partial thromboplastin time reagent composed of synthetic phospholipids: usefulness for monitoring heparin therapy. Clin Chem. 1997;43:1215-1222. (Pubitemid 27297266)
4. Fritsma GA. Laboratory evaluation of hemostasis. In: Rodak BF, Fritsma GA, Keohane EM. Hematology Clinical Principles and Applications. 4th ed. Philadelphia, PA: Elsevier; 2012:642-646.
5. Triplett DA, Harms CS, Koepke JA. The effect of heparin on the activated partial thromboplastin time. Am J Clin Pathol. 1978;70(3 suppl):556-559. (Pubitemid 9109643)
6. Brill-Edwards P, Ginsberg JS, Johnston M, et al. Establishing a therapeutic range for heparin therapy. J Ann Intern Med. 1993;119:104-109. (Pubitemid 23286474)
7. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2009;7:1737-1740.
8. Swadzba J, Iwaniec T, Pulka M, et al. Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines. J Thromb Haemost. 2011;9:1776-1783.
9. Wong RC, Adelstein S, Gillis D, et al. Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing. Semin Thromb Hemost. 2005;3139-3148.
10. Tripodi A. Laboratory testing for lupus anticoagulants: diagnostic criteria and use of screening, mixing, confirmatory studies. Semin Thromb Hemost. 2008;34:373-378.
11. College of American Pathologists Proficiency Testing Surveys: CLG-A. Northfield, IL: College of American Pathologists; 2008-2011.
12. Dembitzer FR, Ledford-Kraemer MR, Meijer P, et al. Lupus anticoagulant testing: performance and practices by North American clinical laboratories. Am J Clin Pathol. 2010;134;764-773.